L

Lannett Company Inc
F:LN5

Watchlist Manager
Lannett Company Inc
F:LN5
Watchlist
Price: 2.254 EUR
Market Cap: 24.3m EUR

Wall Street
Price Targets

LN5 Price Targets Summary
Lannett Company Inc

There are no price targets for LN5.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Lannett Company Inc Competitors:
Price Targets
GLAXO
GlaxoSmithKline Pharmaceuticals Ltd
18% Upside
GLAND
Gland Pharma Ltd
24% Upside
CPH
Cipher Pharmaceuticals Inc
29% Upside
ANCR
Animalcare Group PLC
42% Upside
DMP
Dermapharm Holding SE
15% Upside
524731
Jenburkt Pharmaceuticals Ltd
28% Upside

Revenue
Forecast

Revenue Estimate
Lannett Company Inc

For the last 1 year the compound annual growth rate for Lannett Company Inc's revenue is -29%. The projected CAGR for the next 1 year is 36%.

-29%
Past Growth
36%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Lannett Company Inc

Operating Income forecast
is not available for
Lannett Company Inc

Net Income
Forecast

Net Income Estimate
Lannett Company Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LN5's stock price target?
Not Available

LN5 doesn't have any price targets made by Wall Street professionals.

What is Lannett Company Inc's Revenue forecast?
Projected CAGR
36%

For the last 1 year the compound annual growth rate for Lannett Company Inc's revenue is -29%. The projected CAGR for the next 1 year is 36%.

Back to Top